International Cannabis Weekly: 164

• US Congressional Committee approves the medical cannabis research act.
• Recreational cannabis projects begin to emerge in Europe.
• Prohibition Partners interviews D’ Arcy Bond, Director of Newell Sciences

• The IDPC releases a set of principles for the responsible legal regulation of cannabis.
• Bedrocan resupplies Malta with medical cannabis amid shortages last week.
• Switzerland greenlights adult-use cannabis study for experienced users.
• Luxembourg medical cannabis imports increase as patient numbers rise.
• NHS agrees to provide medical cannabis prescription after a mother sends letter to UK Health Secretary.
• French advocates urge government to begin medical cannabis experiment.
• Scotland approves Epidyolex to treat Dravet syndrome and Lennox Gastaut syndrome.
• UK police chiefs support medicinal cannabis cards for UK patients.
• Sweden approves STENOCARE and Emerald to provide medical cannabis oil to patients.
• French MP supports controlled legalisation of cannabis.

Newell Sciences is a fully integrated cannabinoid producer that delivers high quality cannabinoids to the global market.

LEARN MORE

• New York counties recommend cannabis legalisation to ease budget crisis.
• Nebraska removes medical cannabis legalisation from November ballot.
• Maine issues first active adult-use cannabis business licences.
• USDA funds research to explore the effects of cannabinoids in cattle feed.
• New federal report shows fewer banks are working with cannabis businesses.
• Congressmen introduce a bill to market hemp-derived CBD as a dietary supplement.

• Canadian cannabis manufacturing jobs decline more than one third in H1 2020.
• Aurora appoints new CEO while expecting a writedown in Q4 2020 of CA$1.8 billion.
• Canopy Growth lays off another round of workers as the company restructures.
• Quebec’s monopoly cannabis retailer, SQDC, announces Q1 sales of CA$110.4 million.

• Colombian bill that seeks to legalise adult-use cannabis passes by one vote.
• Medcolcanna and Curativa enter a joint venture for pharmaceutical cannabis products.
• Jamaica’s CLA is committed to facilitating the import and export of cannabis.
• Argentina’s medical cannabis market has the potential to reach US$1 billion in 10 years.

• Australian government proposes a rescheduling of CBD, allowing OTC pharmacy sales.
• New Zealand could earn NZ$1.1 billion in taxes annually from cannabis legalisation.
• Australian government announces clinical medical cannabis grants of AU$3 million.
• Thai study suggests cannabis extracts may inhibit cancer cell growth.

• Zambia moves one step closer to regulating medicinal and industrial hemp.
• Researchers in Israel are using zebrafish to test medical properties of cannabis strains.
• Labat Africa enters negotiations to acquire an undisclosed licensed cannabis cultivator.